Firm close to buying Drive, sources say
By HME News Staff
Updated Thu August 11, 2016
PORT WASHINGTON, N.Y. - Buyout firm Clayton, Dubilier & Rice is in talks to buy Drive DeVilbiss for about $750 million, according to Reuters.
CD&R, whose previous investments have included AssuraMed, which it sold to Cardinal Health for $2.1 billion in 2013, prevailed in an auction and could strike a deal in the coming days, Reuters reported on Aug. 10. As part of the deal, top execs at Drive would join CD&R as minority investors.
Drive, which is partly owned by private equity firm Ferrer, Freeman & Co., has bulked up by making more than half a dozen acquisitions since 2011, most notably DeVilbiss Healthcare last year.
Other healthcare-related properties owned by CD&R include VWR International, which supplies products and services to medical laboratories; Envision Healthcare, which provides outsourced medical devices; and PharMEDium, which provides sterile compounding services.
Comments